Christopher T Rentsch, PhD, FISPE
Biography
Research & Publications
News
Appointments
Biography
Dr Rentsch is an epidemiologist specialising in the use of electronic health records, with a focus on establishing real-world evidence for the safety and effectiveness of medications.
In his roles within the Veterans Aging Cohort Study (VACS) at Yale and the Electronic Health Records (EHR) Research Group at London School of Hygiene & Tropical Medicine, he performs research using some of the largest clinical and genetic cohorts in the world today.
Dr Rentsch has received two prestigious awards from the International Society for Pharmacoepidemiology (ISPE) in 2021 (Emerging Leader Award) and 2022 (Special ISPE Award for his "demonstrable impact on public health related to the COVID-19 pandemic"). In 2024, he was named a Fellow of the International Society of Pharmacoepidemiology and elected to the ISPE Board of Directors.
Dr Rentsch is Co-Chair of the VACS Pharmacoepidemiology Core and Program Director for pharmacoepidemiology and pharmacovigilance training at LSHTM, including:
- Professional Certificate in Pharmacoepidemiology & Pharmacovigilance
- Real-World Evidence in Pharmacoepidemiology
Dr Rentsch was co-Editor of a free, online textbook, "COVID-19 Real-World Evidence Primer," which aims to promote careful design and methodological approaches supporting causal inferences on drug safety and effectiveness that guide clinical and regulatory decisions.
In his spare time, he can be found performing around the UK in the London City Brass band.
Education & Training
- PhDLondon School of Hygiene & Tropical Medicine (2018)
- PGDipLondon School of Hygiene & Tropical Medicine (2017)
- MPHEmory University (2011)
- BAThe Ohio State University (2008)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
FISPE (Fellow of the International Society of Pharmacoepidemiology) | International Society of Pharmacoepidemiology | 2024 |
Special ISPE Award for Contributions to Public Health Associated with the COVID-19 Pandemic | International Society for Pharmacoepidemiology | 2022 |
Emerging Leader Award | International Society for Pharmacoepidemiology | 2021 |
Best Reviewer Award | Pharmacoepidemiology & Drug Safety | 2017 |
Professional Service
Organization | Role | Date |
---|---|---|
ISPE Board of Directors, Academia (Europe/Africa), International Society for Pharmacoepidemiology (ISPE) | Board of Directors | 2024 - Present |
Pharmacoepidemiology (PEPI) Core, Veterans Aging Cohort Study (VACS), US Dept of Veterans Affairs | Co-Chair | 2022 - Present |
COVID-19 Core, Veterans Aging Cohort Study (VACS), US Dept of Veterans Affairs | Co-Chair | 2021 - Present |
Membership Committee, International Society for Pharmacoepidemiology (ISPE) | Chair | 2020 - 2021 |
Polypharmacy Workgroup, Veterans Aging Cohort Study (VACS), US Dept of Veterans Affairs | Co-Chair | 2019 - 2022 |
Methods Training, Real-World Evidence Task Force, International Society for Pharmacoepidemiology (ISPE) | Co-Chair | 2019 - 2022 |
Anti(retro)viral Therapy Workgroup, Veterans Aging Cohort Study (VACS), US Dept of Veterans Affairs | Co-Chair | 2015 - 2022 |